These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 19502649

  • 1. Non-invasive assessment of fibrosis in non-alcoholic fatty liver disease.
    Vizzutti F, Arena U, Nobili V, Tarquini R, Trappoliere M, Laffi G, Marra F, Pinzani M.
    Ann Hepatol; 2009; 8(2):89-94. PubMed ID: 19502649
    [Abstract] [Full Text] [Related]

  • 2. Combined paediatric NAFLD fibrosis index and transient elastography to predict clinically significant fibrosis in children with fatty liver disease.
    Alkhouri N, Sedki E, Alisi A, Lopez R, Pinzani M, Feldstein AE, Nobili V.
    Liver Int; 2013 Jan; 33(1):79-85. PubMed ID: 23146095
    [Abstract] [Full Text] [Related]

  • 3. Characteristics and diagnosis of NAFLD/NASH.
    Hashimoto E, Taniai M, Tokushige K.
    J Gastroenterol Hepatol; 2013 Dec; 28 Suppl 4():64-70. PubMed ID: 24251707
    [Abstract] [Full Text] [Related]

  • 4. Review article: the diagnosis of non-alcoholic fatty liver disease -- availability and accuracy of non-invasive methods.
    Festi D, Schiumerini R, Marzi L, Di Biase AR, Mandolesi D, Montrone L, Scaioli E, Bonato G, Marchesini-Reggiani G, Colecchia A.
    Aliment Pharmacol Ther; 2013 Feb; 37(4):392-400. PubMed ID: 23278163
    [Abstract] [Full Text] [Related]

  • 5. Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: present and future.
    Wieckowska A, McCullough AJ, Feldstein AE.
    Hepatology; 2007 Aug; 46(2):582-9. PubMed ID: 17661414
    [Abstract] [Full Text] [Related]

  • 6. Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease.
    McPherson S, Stewart SF, Henderson E, Burt AD, Day CP.
    Gut; 2010 Sep; 59(9):1265-9. PubMed ID: 20801772
    [Abstract] [Full Text] [Related]

  • 7. The challenge of developing novel pharmacological therapies for non-alcoholic steatohepatitis.
    Schuppan D, Gorrell MD, Klein T, Mark M, Afdhal NH.
    Liver Int; 2010 Jul; 30(6):795-808. PubMed ID: 20624207
    [Abstract] [Full Text] [Related]

  • 8. Non-invasive diagnosis of nonalcoholic fatty liver and nonalcoholic steatohepatitis.
    Adams LA, Feldstein AE.
    J Dig Dis; 2011 Feb; 12(1):10-6. PubMed ID: 21091933
    [Abstract] [Full Text] [Related]

  • 9. Complex non-invasive fibrosis models are more accurate than simple models in non-alcoholic fatty liver disease.
    Adams LA, George J, Bugianesi E, Rossi E, De Boer WB, van der Poorten D, Ching HL, Bulsara M, Jeffrey GP.
    J Gastroenterol Hepatol; 2011 Oct; 26(10):1536-43. PubMed ID: 21950746
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The usefulness of measuring liver stiffness by transient elastography for assessing hepatic fibrosis in patients with various chronic liver diseases.
    Tamano M, Kojima K, Akima T, Murohisa T, Hashimoto T, Uetake C, Sugaya T, Nakano M, Hiraishi H, Yoneda M.
    Hepatogastroenterology; 2012 May; 59(115):826-30. PubMed ID: 22469726
    [Abstract] [Full Text] [Related]

  • 13. Serum ferritin is a discriminant marker for both fibrosis and inflammation in histologically proven non-alcoholic fatty liver disease patients.
    Manousou P, Kalambokis G, Grillo F, Watkins J, Xirouchakis E, Pleguezuelo M, Leandro G, Arvaniti V, Germani G, Patch D, Calvaruso V, Mikhailidis DP, Dhillon AP, Burroughs AK.
    Liver Int; 2011 May; 31(5):730-9. PubMed ID: 21457446
    [Abstract] [Full Text] [Related]

  • 14. Role of liver biopsy and serum markers of liver fibrosis in non-alcoholic fatty liver disease.
    Adams LA, Angulo P.
    Clin Liver Dis; 2007 Feb; 11(1):25-35, viii. PubMed ID: 17544970
    [Abstract] [Full Text] [Related]

  • 15. Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis.
    Gaia S, Carenzi S, Barilli AL, Bugianesi E, Smedile A, Brunello F, Marzano A, Rizzetto M.
    J Hepatol; 2011 Jan; 54(1):64-71. PubMed ID: 20932598
    [Abstract] [Full Text] [Related]

  • 16. Non-alcoholic fatty liver disease: an overview of prevalence, diagnosis, pathogenesis and treatment considerations.
    Preiss D, Sattar N.
    Clin Sci (Lond); 2008 Sep; 115(5):141-50. PubMed ID: 18662168
    [Abstract] [Full Text] [Related]

  • 17. Predictors of steatohepatitis and advanced fibrosis in non-alcoholic fatty liver disease.
    Pagadala M, Zein CO, McCullough AJ.
    Clin Liver Dis; 2009 Nov; 13(4):591-606. PubMed ID: 19818307
    [Abstract] [Full Text] [Related]

  • 18. Liver biopsy versus noninvasive methods--fibroscan and fibrotest in the diagnosis of non-alcoholic fatty liver disease: a review of the literature.
    Pais R, Lupşor M, Poantă L, Silaghi A, Rusu ML, Badea R, Dumitraşcu DL.
    Rom J Intern Med; 2009 Nov; 47(4):331-40. PubMed ID: 21179914
    [Abstract] [Full Text] [Related]

  • 19. Metabolic disturbances in non-alcoholic fatty liver disease.
    Byrne CD, Olufadi R, Bruce KD, Cagampang FR, Ahmed MH.
    Clin Sci (Lond); 2009 Apr; 116(7):539-64. PubMed ID: 19243311
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.